These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 5310287)

  • 41. Albinism and abnormal platelet function.
    Logan LJ; Rapaport SI; Maher I
    N Engl J Med; 1971 Jun; 284(24):1340-5. PubMed ID: 5576453
    [No Abstract]   [Full Text] [Related]  

  • 42. Evidence that von Willebrand factor is not required for the clotting of plasma in the presence of platelets and kaolin (Hardisty-Hutton test).
    McPherson J; Soberano ME; Macdonald C; Zucker MB
    Thromb Haemost; 1984 Apr; 51(2):272-4. PubMed ID: 6429885
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The domain of platelet glycoprotein I as recognized by various antibodies, both monoclonal and polyspecific.
    Bryckaert MC; Ruan C; Tobelem G
    Blood Cells; 1983; 9(2):383-7. PubMed ID: 6229302
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Platelet-vessel wall interaction: from the bedside to molecules.
    Caen JP; Rosa JP
    Thromb Haemost; 1995 Jul; 74(1):18-24. PubMed ID: 8578453
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Measurement of the liberation of platelet factor 4 (PF4) in congenital and acquired thrombopathies].
    Kubisz P; Sultan Y; Delobel J; Caen J
    Rev Eur Etud Clin Biol; 1970; 15(6):698-704. PubMed ID: 5273147
    [No Abstract]   [Full Text] [Related]  

  • 46. [Coagulation analytical studies in coli enterotoxemia in swine].
    Schimmel D; Pospisil Z; Schimmel I; Schulze F; Vogt A
    Arch Exp Veterinarmed; 1977; 31(1):15-27. PubMed ID: 322631
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metabolic disorders of platelets.
    Hellem AJ
    Adv Intern Med; 1973; 17():171-87. PubMed ID: 4593928
    [No Abstract]   [Full Text] [Related]  

  • 48. [Nosographic and pathogenetic considerations on a case of von Willebrand-Jürgens disease].
    Mauro R; Volpe E; Valente A; Buonanno G
    Haematologica; 1969; 54(10):663-84. PubMed ID: 4994284
    [No Abstract]   [Full Text] [Related]  

  • 49. [Case of reduced platelet adhesion with a slight P.T.A. plasma deficit].
    Licenziati M; Smalzi L
    Minerva Med; 1976 Jun; 67(30):1968-9. PubMed ID: 1084499
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Platelet-type von Willebrand's disease.
    Miller JL
    Clin Lab Med; 1984 Jun; 4(2):319-31. PubMed ID: 6437734
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vascular hemostasis: a review.
    Stevens DJ
    Am J Med Technol; 1973 Jun; 39(6):252-7. PubMed ID: 4575338
    [No Abstract]   [Full Text] [Related]  

  • 52. [Contribution to the diagnostic and prognostic value of tests for blood lipid disorders, coagulation disorders and thrombocyte adhesiveness in cerebral vascular disorders].
    Popoviciu L; Pascu I; Waitsuk P; Gáspár S; Palade C; Dulău E; Brendus E
    Stud Cercet Neurol; 1969; 14(1):57-65. PubMed ID: 5823324
    [No Abstract]   [Full Text] [Related]  

  • 53. Haemorrhagic disorders.
    Clink HM
    Br J Clin Pract; 1971 Jun; 25(6):263-70. PubMed ID: 4933315
    [No Abstract]   [Full Text] [Related]  

  • 54. [Congenital thrombopathies].
    Outeiriño Hernanz J; Sánchez Fayos J
    Rev Clin Esp; 1973 Jan; 128(2):93-100. PubMed ID: 4571943
    [No Abstract]   [Full Text] [Related]  

  • 55. The platelet aggregation defect in the von Willebrand-Jürgens-Syndrom on the Aland Islands. The possible existence of an "anti-Willebrand-Factor".
    Jürgens J; Lehmann W; Eriksson A
    Hemostase; 1966 Oct; 6(4):225-31. PubMed ID: 5299356
    [No Abstract]   [Full Text] [Related]  

  • 56. [Comparative evaluation of the methods to determine thrombocyte aggregation and adhesiveness (review of the literature)].
    Guseĭnov ChS; Remizova TA; Rakhmaeva VA
    Lab Delo; 1970; 2():71-7. PubMed ID: 4194499
    [No Abstract]   [Full Text] [Related]  

  • 57. [Quantitative study of bleeding time and platelet function during thrombopenic purpura].
    Dimitriadou C; Sultan Y; Levy-Toledano S; Bernal-Hoyos JE; Caen J
    Nouv Presse Med; 1974 Jun; 3(22):1425-8. PubMed ID: 4546309
    [No Abstract]   [Full Text] [Related]  

  • 58. Abnormalities in platelet function due to defects in the release reaction.
    Weiss HJ
    Ann N Y Acad Sci; 1972 Oct; 201():161-73. PubMed ID: 4539663
    [No Abstract]   [Full Text] [Related]  

  • 59. [On the question of the reduced platelet factor 3 activity in v. Willebrand-Jürgens-syndrome].
    Winckelmann G; Walther C
    Folia Haematol (Frankf); 1964 Oct; 9(2):119-30. PubMed ID: 5300139
    [No Abstract]   [Full Text] [Related]  

  • 60. An attempt to assay the 'Anti-Willebrand Factor'.
    Chandler AB; Stormorken H; Solum NO; Gaarder A
    Scand J Clin Lab Invest; 1965; 17():Suppl 84:129+. PubMed ID: 5295418
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.